Publication Date:
2011-02-12
Description:
Many fields have struggled to develop strategies, policies, or structures to optimally manage data, materials, and intellectual property rights (IPRs). There is growing recognition that the field of stem cell science, in part because of its complex IPRs landscape and the importance of cell line collections, may require collective action to facilitate basic and translational research. Access to pluripotent stem cell lines and the information associated with them is critical to the progress of stem cell science, but simple notions of access are substantially complicated by shifting boundaries between what is considered information versus material, person versus artifact, and private property versus the public domain.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Mathews, Debra J H -- Graff, Gregory D -- Saha, Krishanu -- Winickoff, David E -- New York, N.Y. -- Science. 2011 Feb 11;331(6018):725-7. doi: 10.1126/science.1201382.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Johns Hopkins Berman Institute of Bioethics, Deering Hall, 208, 1809 Ashland Avenue, Baltimore, MD 21205, USA. dmathews@jhu.edu〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/21311015" target="_blank"〉PubMed〈/a〉
Keywords:
*Access to Information
;
Biological Specimen Banks
;
Confidentiality
;
Humans
;
Informed Consent
;
*Intellectual Property
;
*Ownership
;
Public Sector
;
*Stem Cell Research
;
*Stem Cells
;
Tissue Donors
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
